Effect of Phase Ⅰ Cardiac Rehabilitation Program on Efficacy and Cardiac Function Recovery of Patients with Severe Valvular Heart Disease Undergoing Valve Replacement
Objective:To investigate the effect of phase Ⅰ cardiac rehabilitation program on the efficacy and cardiac function recovery of patients with severe valvular heart disease(VHD)undergoing valve replacement.Method:A total of 70 patients with severe VHD who admitted to the Second Affiliated Hospital of Guizhou Medical University from January 2021 to May 2023 were selected as the research objects,all patients were underwent valve replacement,the patients were divided into the control group and the observation group according to the difference of postoperative treatment methods,with 35 cases in each group.The control group was given routine intervention after operation,and the observation group was given phase Ⅰ cardiac rehabilitation program on the basis of the control group.The cardiac function indexes,biomarkers and adverse cardiovascular events at 6 months after operation were compared between two groups.Result:The left ventricular ejection fraction(LVEF)of the observation group at discharge was higher than that of the control group,and the left ventricular end-diastolic diameter(LVEDD)and left ventricular end-systolic diameter(LVESD)were lower than those of the control group,the differences were statistically significant(P<0.05);the levels of B-type brain natriuretic peptide(BNP),troponin I(cTnI)and creatine kinase isoenzyme(CK-MB)in the observation group at discharge were lower than those in the control group,and the differences were statistically significant(P<0.05);the incidence of adverse cardiovascular events in the observation group at 6 months after operation was lower than that in the control group,and the difference was statistically significant(P<0.05).Conclusion:The application of phase Ⅰ cardiac rehabilitation program in patients with severe VHD is remarkable,which can effectively improve cardiac function indexes,biomarkers,and reduce the risk of adverse cardiovascular events.
国家科技期刊平台
NSTL
万方数据
